Express News | Trading Halt: Halt Status Updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times
Moomoo 24/7Apr 17 09:00 ET
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Moomoo 24/7Apr 16 19:50 ET
Sunshine Biopharma Announces Reverse Stock Split
Yahoo FinanceApr 12 09:00 ET
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
Yahoo FinanceApr 1 08:00 ET
Sunshine Biopharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo FinanceMar 31 08:49 ET
Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering
Yahoo FinanceFeb 15 09:15 ET
Analysts Are Optimistic We'll See A Profit From Sunshine Biopharma, Inc. (NASDAQ:SBFM)
Yahoo FinanceJan 23 07:03 ET
Sunshine Biopharma Moves Principal Office to New York City
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM") (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including
GlobeNewswireDec 4, 2023 08:30 ET
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%
MONTREAL, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM") (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including
GlobeNewswireAug 11, 2023 08:30 ET
Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market
MONTREAL, May 16, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includi
GlobeNewswireMay 16, 2023 09:58 ET
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
Globe NewswireMay 12, 2023 08:00 ET
Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%
MONTREAL, May 11, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includi
GlobeNewswireMay 11, 2023 09:00 ET
Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update
MONTREAL, April 05, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas inclu
GlobeNewswireApr 5, 2023 08:06 ET
Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound
MONTREAL, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and
GlobeNewswireFeb 10, 2023 07:35 ET
Sunshine Biopharma Announces Share Repurchase Program
MONTREAL, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includ
GlobeNewswireJan 19, 2023 07:35 ET
Sunshine Biopharma Enters Into a Collaboration Agreement With a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer MRNA Project
MONTREAL, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas, inclu
GlobeNewswireNov 16, 2022 08:06 ET
Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
MONTREAL, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral dr
GlobeNewswireOct 20, 2022 08:06 ET
EXCLUSIVE: Sunshine Biopharma Says 'The Addition of Nora Pharma Allows Sunshine Biopharma to Expand Its Operations Into the Area of Generic Prescription Drugs and Biosimilars'
EXCLUSIVE: Sunshine Biopharma Says 'The addition of Nora Pharma allows Sunshine Biopharma to expand its operations into the area of generic prescription drugs and biosimilars'
Benzinga Real-time NewsOct 20, 2022 07:32 ET
EXCLUSIVE: Sunshine Biopharma Tells Benzinga Co. Announces The Acquisition Of Nora Pharma For $21M In Cash, Common Stock, And An Earn-Out Amount
EXCLUSIVE: Sunshine Biopharma Tells Benzinga Co. Announces The Acquisition Of Nora Pharma For $21M In Cash, Common Stock, And An Earn-Out Amount
Benzinga Real-time NewsOct 20, 2022 07:32 ET
Sunshine Biopharma Files Its Second Quarter Report With the SEC
Company Reports Significant Increase in Cash on Hand as a Result of Recent FinancingsMONTREAL, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW"), a pharmaceutic
GlobeNewswireAug 4, 2022 08:08 ET
No Data
No Data